Prostate Cancer Awareness and Initiative for Screening in the European Union

Enrolling by invitationOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Risk-based screening algorithm

Risk-based screening algorithm

Trial Locations (5)

Unknown

University College Dublin, Dublin

National Cancer Institute, Vilnius

Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw

Public Health Directorate, SERGAS, Santiago de Compostela

Althaia Foundation, Manresa

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

European Randomised Study of Screening for Prostate Cancer

UNKNOWN

collaborator

Region MidtJylland Denmark

OTHER

collaborator

Institute of Health Information and Statistics of the Czech Republic

OTHER_GOV

collaborator

UMC Utrecht

OTHER

collaborator

EUROPEAN CANCER ORGANISATION

UNKNOWN

collaborator

Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

UNKNOWN

collaborator

Narodowy Instytut Zdrowia Publicznego

UNKNOWN

collaborator

Conselleria de Sanidade de Galicia

UNKNOWN

collaborator

Althaia Xarxa Assistencial Universitària de Manresa

OTHER

collaborator

Vastra Gotaland Region

OTHER_GOV

collaborator

Region Skane

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

University Ghent

OTHER

collaborator

Health Service Executive, Ireland

OTHER

collaborator

Estonian Urological Association

UNKNOWN

collaborator

University College Dublin

OTHER

collaborator

WONCA Europe

UNKNOWN

collaborator

Movember Foundation

OTHER

collaborator

International Agency for Research on Cancer

OTHER

collaborator

European Society of Urogenital Radiology

OTHER

collaborator

Europa UOMO

UNKNOWN

collaborator

Czech Urological Society

UNKNOWN

lead

European Association of Urology Research Foundation

OTHER